ClinConnect ClinConnect Logo
Search / Trial NCT07033325

University-Based Chagas Testing in Salta Province, Argentina

Launched by MUNDO SANO FOUNDATION · Jun 23, 2025

Trial Information

Current as of November 11, 2025

Enrolling by invitation

Keywords

Chagas Chagas Rapid Diagnostic Test Trypanosoma Cruzi Salta Argentina

ClinConnect Summary

This study in Argentina is looking at chronic Chagas disease (an infection caused by Trypanosoma cruzi) among adults at the National University of Salta. Researchers want to learn how common the infection is among university students and staff, how it varies by campus, and whether a quick, on-site rapid test can help people get diagnosed and connected to care. It is an observational study, not a drug trial, and will also assess how well university-based testing works in a non-clinical setting.

Eligible people are adults aged 18 and older who are part of the university community (students, teachers, and staff) and who have not previously been diagnosed with Trypanosoma cruzi infection. About 5,000 participants across nine campuses are expected to join on a voluntary basis. At campus screening events, a finger-prick rapid test will be used. If someone tests positive, they will be referred to the public health system for confirmatory testing and possible treatment (benznidazole or nifurtimox) with support from study staff. A small number of negative-test participants may have serum stored for later accuracy checks. The study will also collect information on demographics, residence, exposure history, and knowledge about Chagas disease, with follow-up by phone for those who test positive or enter care. Results will be shared in a de-identified way, and anonymized participant data may be shared with other researchers after the study ends.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • Member of the university community (e.g., student, faculty, administrative staff, or other personnel).
  • Aged 18 years or older.
  • Of any sex or gender.
  • Able and willing to provide informed consent.
  • Exclusion Criteria:
  • - Prior confirmed diagnosis of Trypanosoma cruzi infection.

About Mundo Sano Foundation

Mundo Sano Foundation is a non-profit organization dedicated to improving public health through research, prevention, and treatment of neglected tropical diseases and other infectious diseases. With a strong commitment to social responsibility and scientific innovation, the foundation collaborates with global health partners to develop sustainable solutions that enhance quality of life in underserved communities. Its clinical research initiatives focus on advancing medical knowledge and fostering equitable access to healthcare interventions worldwide.

Locations

Orán, Salta, Argentina

Salta, Argentina

Patients applied

0 patients applied

Trial Officials

Adriana Echazu, PhD

Study Director

Mundo Sano Foundation

Ruben O Cimino, PhD

Study Chair

Instituto de Investigaciones de Enfermedades Tropicales, Univeridad Nacional de Salta

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported